An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

This study is open to children and young adults up to 22 years old who have recently been diagnosed with ependymoma. All patients will have their diagnosis confirmed by experts before joining. Girls who have started their periods must not be pregnant or breastfeeding, and they'll need to use effective birth control during and for six months after the study treatment. Similarly, boys who could father a child will also need to use effective birth control for the same period.

There are certain health requirements to be part of the study. You shouldn't have any serious health conditions that are not related to your ependymoma that would make chemotherapy unsafe. Your blood, liver, and kidney functions need to be healthy enough to receive the treatments, and you shouldn't have any active infections. Also, you must not have received previous radiation or chemotherapy for this condition, except for steroids.

Depending on whether all of your tumour was removed during the first surgery and your age, you might fit into one of the different study groups. For example, some groups are for patients aged over 12 months and under 22 years whose tumour was completely removed, while other groups are for those in the same age range but with some tumour remaining that couldn't be surgically removed.

If you decide to take part, your images and tumour samples will first be reviewed by experts to confirm your diagnosis and help decide the best treatment path. This might also involve discussing another surgery if it's considered helpful. You'll then be placed into one of three different treatment groups based on your age and the results of your surgery. Each group involves specific treatments like chemotherapy (e.g., VEC, CDDP, HD-MTX, Valproate) and radiotherapy, which is a common cancer treatment using high-energy rays.

Depending on your group, you might receive a course of chemotherapy for about 16 weeks, alongside or followed by radiotherapy. For some, if a small part of the tumour remains after initial therapy, an additional small dose of radiotherapy might be given. You'll have regular hospital visits for these treatments and to monitor your health. The total duration of your participation will depend on the specific treatment plan, but it will involve ongoing assessments and follow-up care for a period after treatment ends.